The 39-year-old Reigns continues to perform at the highest level in professional wrestling and competed in the main event of ...

A mom in Australia discovered her young son had leukemia after taking him to get a possible bite checked out following a ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...

LOS ANGELES (KTLA) – With the devastating Palisades Fire still smoldering, Lisa Pelton and some of her neighbors in Mandeville Canyon received an unpleasant notice from their bank: their home equity ...

Boston – Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy ...

Treosulfan plus fludarabine was approved by the FDA for children and adults with AML or MDS before allogenic hematopoietic ...

The Business Research Company's Key Market Driver in Elitek or Fasturtec industry 2025: Rising Leukemia Prevalence Fuels Market Growth LONDON, GREATER LONDON, UNITED KINGDOM, January 25, 2025 ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...

The combination of treosulfan and fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation ...

After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.